Highlights from the last week in the biosphere:
- We launched Bio Markets, delivering real-time market insights on projects in the Bio ecosystem and DeSci economy, including analytics on project mindshare, growth trends and in-app trading for BioDAOs, with trading for IP-Tokens & new BioAgents coming soon.
- The number of BIO staked rose to over 125M with over 3.5% of BIO's circulating supply now staked on the protocol generating BioXP for upcoming Ignition Sales. Yapping BioXP goes live in the app this week, with a live boost campaignfor BioAgents.
- Bio approved a proposal to fund a human clinical trial conducted by @Cerebrum_DAO assessing the effect of its patented supplement Percepta® on human cognition in exchange for a % of $CLAW tokens (Percepta's IP-Token).
- Molecule announced it is developing its V2 protocol to bridge traditional corporate structures into DeSci and drive institutional adoption, while also launching a new product hub with prescription treatments, supplements and merch, all developed by the DeSci economy.
🧪 Bio Markets
We launched the new Bio Markets page, bringing real-time DeSci market intel and instant trading for $BIO and Bio ecosystem assets all in one place. Track ecosystem analytics and project mindshare to see where the onchain science economy is heading. Filter assets by type (IP-Tokens, BioDAOs, BioAgents) and blockchain.
The first BioAgents, going live in the coming weeks via the first-ever Bio V2 Ignition Sales, will be added post-launch to Bio Markets for seamless tracking and in-app trading.
🧠 $CLAW Brain Health Study Funded
Cerebrum DAO's proposal was approved to raise $80k from the Bio Treasury to fund a human clinical trial for Percepta®, a patented brain health supplement.
The study will addi the pTau-217 blood biomarker to provide robust evidence of Percepta's efficacy in improving cognitive performance and mitigating early memory loss. Cerebrum also shared a sneak peek of the Cerebrum Cortex App, including a BrainHealth Index, Brain Fitness Score using a proprietary algorithm, a NEURON token reward system, and more.
Read the Percepta funding proposal:
🥼 Molecule V2 Introduces Hybrid Token-Equity Structure for DeSci
Molecule Protocol V2, now in closed beta, announced it is integrating traditional corporate structures into DeSci assets to drive institutional adoption of DeSci.
Molecule V2 introduces a hybrid token-and-equity framework that tokenizes scientific IP as blockchain-based Real-World Assets (RWAs), boosting liquidity, ensuring compliance, enhancing investor appeal, while promoting decentralized, community-driven scientific innovation.
Molecule also launched the DeSci Shop, a hub for products such as supplements, merch, prescription treatments, and more, all born from DeSci projects like VitaDAO, PsyDAO, HairDAO, and Cerebrum DAO.
🌐 Ecosystem Updates
- PsyDAO's $BeeARD project's AI scientist discovered a novel psilocybin derivative with potential to boost mitochondrial production, reduce oxidative stress & more. Dive deeper in their X Spaces with Molecule. PsyDAO also rolled out BeeARD upgrades including conversational querying, allowing users to ask for explanations of generated hypotheses, and assess funding feasibility. Pump Science also selected them to be the drug dev for the upcoming launch of the LSD compound on their platform.
- Pump Science crowned Rapamycin as the new "king of the pill" after outperforming other compounds in extending worm lifespan by +35%, with plans for further testing in flies.
- Quantum Biology DAO is advancing its TIRF microscopy-based quantum microscope, with a successfully calibrated high-power electromagnet for precise control of rotating magnetic fields. The optical system is nearing completion, and a recently installed three-phase power system enhances electromagnet precision, enabling accurate study of quantum effects in living cells using laser light transmitted through a thin glass cable.
- SpineDAO introduced Soul Bound Tokens (SBTs) for non-transferable clinician identities to label anonymized spine care data for AI training, including a peer-review system to boost accuracy beyond general models, and rewards contributors with SPINE tokens.
- Long Covid Labs shared two governance proposals: one to allocate tokens for core contributors and another outlining a 12-month budget to fund key roadmap initiatives, including the Patient Grant Fund and Patient Registry.
- Curetopia hosted its weekly lab meeting to discuss the latest updates on its CureARS pipeline and compound testing on ~40 targets.
- HairDAO bridged to Base, completed the primary staining of 72 tissue sections in 1 day, & spoke at the "World of Apps" event by Ethereum NYC.
- AthenaDAO will host their Demo Day Premiere on August 20th showcasing advancements in AI-driven reproductive longevity, decentralized clinical trials, fertility acceleration and women’s health R&D.
- Spectruth DAO had 200+ people apply for their ambassador program to help expand their PTSD mission & earn token rewards.
- ReflexDAO's curation phase is now sunset with plans to launch on Bio V2. If you've curated BIO for REFLEX, it can be withdrawn in the app with no fees. Withdraw your BIO here.
Bio Community Updates
- Bio is offering a 1M BioXP Boost to the top creators producing original threads or ELI5-style explanations of BioAgents in any language, with 100K BioXP awarded to the top 5 entries in both categories. Contest ends tomorrow, Monday Aug 18 23:59 UTC - Submit here.
- Curetopia will host a DeSci dinner on August 21, at Coinfest Asia in Bali, exploring how DeSci funds bold ideas, supports overlooked fields, and transforms onchain scientific discovery. Apply to join
- dYdX listed BIO on their Launchable Market, while Aerodrome announced a BIO/WETH pool, enhancing liquidity and visibility in the Bio ecosystem, with all BioDAO pools on Mainnet, Base and Solana live and running.
Explore new DeSci projects in the Bio Ecosystem on Bio App 🧪
Stay updated via our Telegram, Discord & Governance forum. Follow @BioProtocolEco on X for real-time ecosystem updates.
